Orthotopic liver transplant using allografts from geriatric population in the United States: Is there any age limit?

Experimental and Clinical Transplantation

Volumn 8, Issue 3, 2010, Pages 196-201

  Singhal, Ashish ^a   Sezginsoy, Banu ^b   Ghuloom, Adel E ^a   Hutchinson, Ian V ^c   Cho, Yong W ^c   Jabbour, Nicolas ^a  

^a INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Donor age; Octogenerian; Older donors; Organ shortage; Survival

Indexed keywords

ADULT; AGE; AGED; AGING; ALLOTRANSPLANTATION; ARTICLE; CONTROLLED STUDY; DONOR SELECTION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DATABASES AS TOPIC; DONOR SELECTION; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNITED STATES;

EID: 77957132624     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kampmann JP, Sinding J, Moller-Jorgensen I. Effect of age on liver function. Geriatrics. 1975;30(8):91-95.
2. Popper H. Aging and the liver. Prog Liver Dis. 1986;8:659-683.
3. Wall WJ, Mimeault R, Grant DR, Bloch M. The use of older donor livers for hepatic transplantation. Transplantation. 1990;49(2):377-381.
4. Marino IR, Doyle hazard ratio, Doria, C et al. Outcome of liver transplantation using donors 60-79 years of age. Transplant Proc 1995;27:1184-1185.
5. Washburn WK, Johnson LB, Lewis WD, Jenkins RL. Graft function and outcome of older (> or = 60 years) donor livers. Transplantation. 1996;61(7):1062-1066.
6. Grande L, Rull A, Rimola A, et al. Outcome of patients undergoing orthotopic liver transplantation with elderly donors (over 60 years). Transplant Proc. 1997;29(8):3289-3290.
7. Healey PJ, Davis CL. Transmission of tumours by transplantation. Lancet. 1998;352(9121):2-3.
8. Wall W, Grant D, Roy A, Asfar S, Block M. Elderly liver donor. Lancet. 1993;341(8837):121.
9. Emre S, Schwartz ME, Altaca G, et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation. 1996;62(1):62-65.
10. Jiménez Romero C, Moreno González E, Colina Ruíz F, et al. Use of octogenarian livers safely expands the donor pool. Transplantation. 1999;68(4):572-575.
11. Grazi GL, Cescon M, Ravaioli M, et al. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant. 2001;1(1):61-68.
12. Cuende N, Grande L, Sanjuán F, Cuervas-Mons V. Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age. Transplantation. 2002;73(8):1360.
13. Mazziotti A, Cescon M, Grazi GL, et al. Successful liver transplantation using an 87 year-old donor. Hepatogastroenterology. 1999;46(27):1819-22.
14. Nardo B, Masetti M, Urbani L, et al. Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant. 2004;4(7):1139-1147.
15. www.unos.org
16. DeBakey ME, Lawrie GM, Glaeser DH. Patterns of atherosclerosis and their surgical significance. Ann Surg. 1985;201(2):115-131.
17. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387-1395.
18. Franzén LE, Ekstedt M, Kechagias S, Bodin L. Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol. 2005;18(7):912-916.
19. Fiorini RN, Kirtz J, Periyasamy B, et al. Development of an unbiased method for the estimation of liver steatosis. Clin Transplant. 2004;18(6):700-706.
20. Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997;64(2):248-251.
21. Berenguer M. Risk of extended criteria donors in hepatitis C viruspositive recipients. Liver Transpl. 2008;14(suppl 2):S45-S50.
22. Briceño J, Marchal T, Padillo J, Solórzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation. 2002;74(4):522-526.
23. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-470.
24. Amin MG, Wolf MP, TenBrook JA Jr, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl. 2004;10(12):1468-1475.
25. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant. 2005;5(2):307-313.
26. Doyle MB, Anderson CD, Vachharajani N, et al. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival. Arch Surg. 2008;143(7):679-685; discussion 685.
27. Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant. 2005;5(3):549-557.
28. Borchert D, Glanemann M, Mogl M, Langrehr JM, Neuhaus P. Older liver graft transplantation, cholestasis and synthetic graft function. Transpl Int. 2005;18(6):709-715.
29. Kim DY, Cauduro SP, Bohorquez HE, Ishitani MB, Nyberg SL, Rosen CB. Routine use of livers from deceased donors older than 70: is it justified? Transpl Int. 2005;18(1):73-77.
30. Le Couteur DG, Warren A, Cogger VC, et al. Old age and the hepatic sinusoid. Anat Rec (Hoboken). 2008;291(6):672-683.